15 octubre 2015
Scientists have shown why a drug widely used to treat chemotherapy-induced anemia in ovarian and breast cancer patients also may shorten survival times in some patients by inadvertently stimulating tumor growth.
http://www.sciencedaily.com/releases/2015/10/151015131846.htm
